⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Hybernia Medical and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Hybernia Medical
↗Uniondale, New York, USA
Hybernia Medical is a clinical-development stage medical device company focused on developing innovative endovascular systems for the treatment of acute organ ischemia, particularly acute ischemic stroke. The company's flagship technology, the Delta-H Cooling Technology, utilizes a smart catheter system to provide selective brain cooling (local hypothermia) to protect brain tissue during endovascular stroke procedures.
Originally a spin-off from Columbia University, the company emphasizes metabolic engineering of ischemic tissue through controlled thermal modulation. Their approach aims to reduce ischemic damage and reperfusion injury by providing real-time, physiology-driven organ resuscitation solutions.
CLASSIFICATION
Company Type:MedTech
Therapeutic Areas:-
Industry:Medical Devices
Sub-Industry:Neurovascular / Stroke Treatment
SIZE & FINANCIALS
Employees:1-50
Revenue:$0.1M-$1M
Founded:2006
Ownership:private
Status:operating
FUNDING
Stage:Series A
Total Raised:$3.71M
Investors:National Institutes of Health (NIH), New York State, The Dana Foundation
PIPELINE
Stage:Clinical
Lead Drug Stage:Clinical development / First-in-human study
Modalities:Endovascular catheter system, Local hypothermia
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Columbia University (Originating institution)
COMPETITION
Position:Emerging
Competitors:Shape Memory Medical, Instylla, Innova Vascular
LEADERSHIP
Key Executives:
John Pile-Spellman - Co-Founder and Chairman
Scientific Founders:John Pile-Spellman
LINKS
Website:hyberniamedical.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Hybernia Medical. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.